NCT03836248 Study of the Contribution of Osteopathic Treatment to Classic Medical Management in Patients With Chronic Low Back Pain
| NCT ID | NCT03836248 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Clinique Pasteur |
| Condition | Chronic Low Back Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 199 participants |
| Start Date | 2019-10-02 |
| Primary Completion | 2028-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 199 participants in total. It began in 2019-10-02 with a primary completion date of 2028-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The management of chronic low back pain is now part of a multi-disciplinary set of proposals with the aim of adapting for each patient orientations of both medicated and non-medicated care. Very classically, analgesic treatment of stage I or II is of use, reinforced by the occasional use of NSAIDs in the absence of contraindication. In this medical attempt of the control of the pain associates a physical care (supervised exercises, physiotherapy care), cognitive and behavioral therapy, multidisciplinary care. Osteopathic treatment is a specific manual diagnostic and therapeutic procedure. This study aims to evaluate the relevance of providing osteopathic treatment in combination with classical medical treatment in the management of patients with chronic non-specific low back pain.
Eligibility Criteria
Inclusion Criteria: * Patient with chronic non-specific low back pain: degenerative lumbalgia and low back pain unrelated to anatomical lesions that have been evolving for more than 3 months. * Patient affiliated with a social security scheme or equivalent * Patient having signed the study informed consent form. Exclusion Criteria: * Patient with specific low back pain: patient with one of the following pathologies: degenerative neurological pathology; infectious pathology; fracture vertebral lesion less than 1 year; vertebral osteosynthesis material or canal narrowing. * Patient following a treatment of the Morphinic or Neuroleptic type. * Pregnant, breastfeeding or parturient woman * Patient participating in another clinical study * Protected patient: Major under some form of guardianship ; Hospitalized without consent
Contact & Investigator
Barthélémy De Truchis de Varennes, MD
PRINCIPAL INVESTIGATOR
Clinique Pasteur
Frequently Asked Questions
Who can join the NCT03836248 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 64 Years, studying Chronic Low Back Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03836248 currently recruiting?
Yes, NCT03836248 is actively recruiting participants. Contact the research team at bdetruchis@clinique-pasteur.com for enrollment information.
Where is the NCT03836248 trial being conducted?
This trial is being conducted at Toulouse, France.
Who is sponsoring the NCT03836248 clinical trial?
NCT03836248 is sponsored by Clinique Pasteur. The principal investigator is Barthélémy De Truchis de Varennes, MD at Clinique Pasteur. The trial plans to enroll 199 participants.